search www.celgene.com submit united states australia english austria deutsch belgium fran ais nederlands canada english fran ais china czech republic e tina denmark dansk europe english finland suomi france fran ais germany deutsch hungary magyar ireland english italy italiano japan luxembourg fran ais nederlands malaysia english mexico espa ol netherlands nederlands norway norsk poland polski portugal portugu s russia singapore english slovakia sloven ina slovenia sloven ina south korea spain espa ol sweden svenska switzerland deutsch taiwan thailand english turkey t rk united kingdom english united states english about our story awards & recognition history values our values our behaviors our community our purpose employees leadership senior management board of directors and committees compliance code of business conduct and ethics sunshine act faq ca declaration of compliance vermont prescriber information diversity global office network therapies anti counterfeiting research & development pipeline medical innovation imids anti inflammatory compounds kinase inhibitors r & d locations citre celgene avilomics research celgene cellular therapeutics cell therapy organ & tissue therapeutics selected cct publications drug discovery & alliance development research oncology clinical trials celgene sponsored trials investigator initiated trials clinical trials data sharing celgene medical affairs educational grant requests areas of focus grant application requirements budget guidelines grant application deadlines request for proposal change of scope budget reconciliation & evaluation outcomes help resources celgene medical information medical information request form responsibility patients & communities celgene support sponsorships & donations charitable & philanthropic contributions light the night pancreatic cancer action network purplestride innovation impact awards 2016 awards overview 2015 innovation impact winners access to medicine principles for pricing innovative medicines european patient group support efpia spend transparency disclosure commitment to safety patient safety employee safety global health governance sustainability governance compliance & ethics reportable allegations filing an online report country access codes public policy engagement association memberships supply chain environment & sustainability environmental management sustainable facilities awards & designations cdp carbon disclosure project newsroom media contacts multimedia library press releases events patients celgene patient support online patient resources rems pharmacy network glossary medical professionals partnerships business development partnerships global health partnerships advocacy partnerships suppliers investors careers contact us october 13 2016 redirecting immune cells to fight myeloma bispecific antibodies can be developed to activate the immune system to fight blood cancer . read more october 10 2016 why federal oral parity legislation is urgently needed today congress can act now to protect 93 million americans from outdated policies . read more september 29 2016 light the night why i m walking this year lymphoma survivor ed svec explains the motivation behind his participation . read more september 28 2016 celgene and national psoriasis foundation launch the first everpsoriatic arthritis awareness day read more celgene treatments find a therapy abraxane istodax otezla pomalyst revlimid thalomid vidaza lifebankusa go to therapies learn more about our portfolio of treatment and services pipeline helping people live longer better healthier lives . celgene treatments find a therapy abraxane istodax otezla pomalyst revlimid thalomid vidaza lifebankusa go to therapies learn more about our portfolio of treatment and services pipeline helping people live longer better healthier lives . september 28 2016 fighting blood cancer on the hill share on facebook share on twitter share on linkedin share on google plus share on pinterest value of medical innovation learn about the discovery and development of our therapies that help save and extend lives . patients learn about our commitment to and services for patients . responsibility learn how our business decisions reflect our values . september 26 2016 medicare part d 10 years of successfully meeting seniors needs share on facebook share on twitter share on linkedin share on google plus share on pinterest september 20 2016 employees facing higher prescription deductibles copays share on facebook share on twitter share on linkedin share on google plus share on pinterest september 19 2016 myelodysplastic syndromes in focus share on facebook share on twitter share on linkedin share on google plus share on pinterest september 16 2016 more african americans needed in myeloma studies share on facebook share on twitter share on linkedin share on google plus share on pinterest september 15 2016 our commitment to multiple sclerosis share on facebook share on twitter share on linkedin share on google plus share on pinterest september 12 2016 a challenging yet rewarding journey towards a myeloma cure share on facebook share on twitter share on linkedin share on google plus share on pinterest september 8 2016 acute myeloid leukemia remains a struggle share on facebook share on twitter share on linkedin share on google plus share on pinterest september 7 2016 living with lymphoma share on facebook share on twitter share on linkedin share on google plus share on pinterest value of medical innovation learn about the discovery and development of our therapies that help save and extend lives . patients learn about our commitment to and services for patients . responsibility learn how our business decisions reflect our values . follow celgene celgene on facebook celgene on twitter celgene on linkedin celgene on google plus celgene on youtube celgene on pinterest about celgene celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide . at celgene we seek to deliver truly innovative and life changing treatments for our patients . global networkhave a question or concern contact ussite map about therapies research & development research oncology responsibility newsroom pipeline value of medical innovation patients medical professionals partnerships investors careers copyright 2016 celgene corporation privacy policy terms of use newsroom media contacts multimedia library press releases events x you are now leaving www.celgene.com a website provided by celgene . this link will take you to a website to which this privacy policy does not apply . we encourage you to read the privacy policy of every website you visit . celgene does not endorse and or influence the content found on websites not owned operated by celgene . continueto view cancelto return to www.celgene.com these products may not be approved and or licensed in all countries where this website is accessible . for information about celgene products and services in countries other than the u.s. please contact the local office as listed under the global network . continueto view cancelto return to www.celgene.com x beware of fraudulent and misleading emails being sent by unauthorized persons for job interviews offers at celgene corporation . these messages are being sent to cheat individuals . celgene never requires any payment to be made by any candidate to celgene or to any individual or agency as part of our recruitment process . celgene will never ask for bank account or credit card information pre hire . please report any such activity to frank marrero . for authentic information about celgene s hiring please visit celgene s official careers website . continue to careers go to celgene.com x the csr synopses posting is for informational purposes only and is not intended to have any legally binding effect . continue go back